CNTA
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc (CNTA) has 10 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 24, 2026.
- Industry:Biotechnology
- CEO:Mario Alberto Accardi
- Employees:77
- HQ:Altrincham, GB
- IPO:2021-05-28
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$6.3B
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
Medicxi Ventures Management (Jersey) LtdFirst filing | 10% Owner | Sale | 19,963,157 | — | Jun 24 | SEC ↗ |
Related companies
Centessa Pharmaceuticals plc is in the Healthcare sector.